Tag: prostate cancer

May 14, 2019

Progenics Pharmaceuticals and ROTOP Pharmaka GmbH Announce European Collaboration

Progenics Pharmaceuticals (NASDAQ:PGNX) has announced an exclusive agreement with ROTOP Pharmaka GmbH to develop and commercialize Progenics’ 1404 prostate specific...
October 29, 2018

TESARO Announces Achievement of ZEJULA Prostate Cancer Development Milestones by Janssen

TESARO (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the achievement of development milestones that trigger an $18 million payment from...
September 28, 2018
May 10, 2018

Aptevo Therapeutics Reports First Quarter 2018 Financial Results

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and...
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 9, 2018

OPKO Health Reports First Quarter 2018 Financial Results

OPKO Health (NASDAQ:OPK) reports financial results and business highlights for the three months ended March 31, 2018. As quoted in...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.